Disease-modifying therapies for Alzheimer’s disease are advancing the science. But translating this clinical progress in to patient experience is proving a challenge. The question Disease-modifying treatments for Alzheimer’s disease have been developed...
Dementia impacts the lives of those who are diagnosed as well as their caregivers. Rare Dementia Support believe that decisions about dementia treatment and care should consider both people living with dementia...
Alzheimer’s disease and other forms of dementia affect more than just the patient. But our research suggests the impact on caregivers remains largely absent from the trials defining value for disease-modifying therapies for...
Reporting on the inaugural OPEN Scientific buyout program At OPEN Health, we bring clarity and confidence to the decisions that shape patient care. That clarity and confidence exist in part because we...
Authors: E Arcà, A Barlassina, A Eze, V Strammiello Published: Journal of Market Access & Health Policy, 2026 View publication Objectives This study explores the feasibility and value of integrating structured patient...
Authors: J Smith, B Talon, A Martinez, K McCarrier, J Aggarwal Published: Frontiers in Dementia, 2025 View publication Background Agitation is a common neuropsychiatric symptom of Alzheimer’s dementia. Limited qualitative evidence is...
Authors: D Mohan, H Clarke, N Ramachandran, J Seo Published: The Patient, 2025 View publication Background Migraine care is often suboptimal owing to undertreatment, variation in clinical outcomes and administration methods among...
Authors: C J Whiffin, K J O Khu, B G Smith, I Kuhn, S M Selveindran, L Hobbs, S Davoody, Y Docrat, O Mantle, U Nath, L Onbaşı, S Tumpa, I N...
Authors: B Coxam, F Sheikh, H Kew, M Fraser, B Levick, C Rolfe, T Ellison, K G Pollock Published: BMJ Open, 2025 View publication Objectives Inflammatory bowel diseases (IBDs) and multiple sclerosis...